Clinical Reviews of JCV and PML, A Supplement to Neurology Reviews
Dec 1, 2011, S15-S20
An active effort is under way to further define risk stratification factors that may reduce the risk of PML. Enhanced clinical vigilance and the identification of factors associated with improved prognosis may improve outcomes.
Frost RL, MJ; Foley, JF; Hopkins, MO
Sep 30, 2011, EEG Peak Alpha Frequency and Cognitive Performance in Patients with Multiple Sclerosis
Vermersch P, Kappos L, Gold R
Sep 30, 2011, Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Foley J
Sep 29, 2011, The Epidemiology of Progressive Multifocal Leukoencephalopathy